Abstract | OBJECTIVE: RESEARCH DESIGN AND METHODS: Patients self-identified as Hispanic from a previous study were included in this exploratory post hoc analysis. Patients were randomized to metformin plus colesevelam or metformin plus placebo. The primary efficacy parameter was the mean change in glycated hemoglobin (HbA1c) levels from baseline. RESULTS: CONCLUSION:
|
Authors | Julio Rosenstock, Eric Hernandez-Triana, Yehuda Handelsman, Soamnauth Misir, Michael R Jones, Sukumar Nagendran |
Journal | Postgraduate medicine
(Postgrad Med)
Vol. 124
Issue 4
Pg. 7-13
(Jul 2012)
ISSN: 1941-9260 [Electronic] England |
PMID | 22913889
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anticholesteremic Agents
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Lipoproteins
- Allylamine
- Metformin
- Cholesterol
- Colesevelam Hydrochloride
|
Topics |
- Allylamine
(adverse effects, analogs & derivatives, therapeutic use)
- Anticholesteremic Agents
(adverse effects, therapeutic use)
- Cholesterol
(blood)
- Colesevelam Hydrochloride
- Diabetes Mellitus, Type 2
(drug therapy, ethnology)
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin
(analysis)
- Hispanic or Latino
- Humans
- Hypoglycemic Agents
(adverse effects, therapeutic use)
- Lipoproteins
(blood)
- Male
- Metformin
(adverse effects, therapeutic use)
- Treatment Outcome
|